<?xml version="1.0" encoding="UTF-8"?>
<ref id="B110-vaccines-08-00098">
 <label>110.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Brehm</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Kenney</surname>
    <given-names>L.L.</given-names>
   </name>
   <name>
    <surname>Wiles</surname>
    <given-names>M.V.</given-names>
   </name>
   <name>
    <surname>Low</surname>
    <given-names>B.E.</given-names>
   </name>
   <name>
    <surname>Tisch</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Burzenski</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Mueller</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Greiner</surname>
    <given-names>D.L.</given-names>
   </name>
   <name>
    <surname>Shultz</surname>
    <given-names>L.D.</given-names>
   </name>
  </person-group>
  <article-title>Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression</article-title>
  <source>FASEB J.</source>
  <year>2019</year>
  <volume>33</volume>
  <fpage>3137</fpage>
  <lpage>3151</lpage>
  <pub-id pub-id-type="doi">10.1096/fj.201800636R</pub-id>
  <pub-id pub-id-type="pmid">30383447</pub-id>
 </element-citation>
</ref>
